European photonics scientists are developing an ultrasensitive laser sensor that detects coronavirus at the earliest point of infection from a saliva or nasal swab in minutes.
Responding to the European Commission’s Express Calls to tackle the coronavirus pandemic, photonics scientists are developing a new rapid, non-invasive ‘optical biosensor’ demonstrator that will detect Covid-19 in humans as soon as it is present in the body.
Having already created six working laboratory demonstrators for other applications, the research team says the technology still needs further adaptation and testing but could be available in a year at the latest.
Originally developed to look for bacterial infections or cancer biomarkers, the new ultrasensitive detector uses photonics – technology that manipulates light – to detect infections in patients with a small amount of the virus.
With the ability to diagnose in real-time with high specificity from a low concentration sample, the sensor is much more reliable than the coronavirus rapid-test, ‘finger-prick’ kit which detects if a person has had the coronavirus before and has since recovered.
Looking at tiny molecules, the new point-of-care detector examines virus antigens using miniaturised chips – or ‘nanophotonic biosensors’ – from a simple nasal or saliva swab.
Once a sample is prepared and is in place, the device confirms a positive or negative for coronavirus instantaneously. However, allowing for preparation time and analysis, a result – from sample to diagnosis – may take up to 30 minutes.

Testing

Calling themselves CONVAT and coordinated at ‘ICN2’ (the Catalan Institute of Nanoscience and Nanotechnology, Spain) the researchers have tested the demonstrators on patients’ samples provided by Vall D´Hebrón Hospital in Barcelona and several other hospitals in Spain for other pathologies.
Project coordinator, Professor Laura Lechuga said: “With thousands of deaths worldwide, we are in urgent need of a rapid new testing kit that is accurate, highly sensitive, non-invasive and cheap to produce”.
“We are currently integrating all the instrumentation in a portable 25x15x25 cm box with a tablet control. At present, our detector is user-friendly, with the preparation being only technical expertise required, and could be widely deployed for GPs or nurses to test patients.”
“Our nanosensor is capable of detecting RNA strands which will fully identify the new coronavirus.”

Image Credit:  AP

read the full article

News This Week

A potential milestone in cancer therapy

Researchers from the University of Bern, Inselspital, University Hospital Bern, and the University of Connecticut have made a significant breakthrough in the fight against cancer. They identified a previously unknown weak point of prostate [...]

Cancer and AI – Can ChatGPT Be Trusted?

A study published in the Journal of The National Cancer Institute Cancer Spectrum delved into the increasing use of chatbots and artificial intelligence (AI) in providing cancer-related information. The researchers discovered that these digital resources accurately [...]